7.75
price up icon8.24%   0.59
after-market Handel nachbörslich: 7.75
loading
Schlusskurs vom Vortag:
$7.16
Offen:
$7.16
24-Stunden-Volumen:
270.63K
Relative Volume:
1.68
Marktkapitalisierung:
$109.76M
Einnahmen:
$1.54M
Nettoeinkommen (Verlust:
$-38.70M
KGV:
-1.6595
EPS:
-4.67
Netto-Cashflow:
$-36.86M
1W Leistung:
-10.61%
1M Leistung:
+5.59%
6M Leistung:
-35.63%
1J Leistung:
-83.86%
1-Tages-Spanne:
Value
$7.16
$7.76
1-Wochen-Bereich:
Value
$6.72
$8.7001
52-Wochen-Spanne:
Value
$4.64
$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
Firmenname
Corbus Pharmaceuticals Holdings Inc
Name
Telefon
617-963-0103
Name
Adresse
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
Mitarbeiter
28
Name
Twitter
@corbuspharma
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
CRBP's Discussions on Twitter

Vergleichen Sie CRBP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
7.75 109.76M 1.54M -38.70M -36.86M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-28 Eingeleitet William Blair Outperform
2024-12-02 Eingeleitet Piper Sandler Overweight
2024-07-30 Eingeleitet Wedbush Outperform
2024-07-22 Fortgesetzt H.C. Wainwright Buy
2024-06-26 Eingeleitet B. Riley Securities Buy
2024-06-03 Bestätigt Oppenheimer Outperform
2024-05-13 Eingeleitet RBC Capital Mkts Outperform
2024-03-06 Hochstufung Jefferies Hold → Buy
2020-09-08 Herabstufung BTIG Research Buy → Neutral
2020-09-08 Herabstufung Jefferies Buy → Hold
2020-09-08 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2020-09-08 Herabstufung ROTH Capital Buy → Neutral
2020-07-07 Eingeleitet ROTH Capital Buy
2020-06-17 Eingeleitet BTIG Research Buy
2020-03-26 Eingeleitet Nomura Buy
2019-04-05 Eingeleitet Jefferies Buy
2019-03-20 Eingeleitet Oppenheimer Outperform
2019-01-11 Bestätigt Cantor Fitzgerald Overweight
2018-12-26 Eingeleitet H.C. Wainwright Buy
2018-12-07 Eingeleitet RBC Capital Mkts Outperform
2018-10-24 Eingeleitet B. Riley FBR Buy
2018-01-19 Eingeleitet Raymond James Outperform
2017-12-14 Bestätigt Cantor Fitzgerald Overweight
2017-11-08 Bestätigt Noble Financial Buy
2017-09-29 Fortgesetzt Noble Financial Buy
2017-03-30 Bestätigt Cantor Fitzgerald Overweight
2016-11-15 Bestätigt JMP Securities Mkt Outperform
2016-11-11 Bestätigt Noble Financial Buy
Alle ansehen

Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten

pulisher
Jun 17, 2025

Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data? - Seeking Alpha

Jun 17, 2025
pulisher
Jun 15, 2025

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $50.88 - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Buys 7,207 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 13, 2025
pulisher
Jun 08, 2025

11,027 Shares in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Bought by Two Sigma Advisers LP - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

(CRBP) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Has $341,000 Stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Dermatomyositis Market Predicted to See Upsurge Through 2034, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Purchases 91,205 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Deutsche Bank AG - Defense World

Jun 04, 2025
pulisher
May 29, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Millennium Management LLC - Defense World

May 29, 2025
pulisher
May 29, 2025

Northern Trust Corp Acquires 11,400 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 29, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 27, 2025
pulisher
May 26, 2025

(CRBP) Proactive Strategies - news.stocktradersdaily.com

May 26, 2025
pulisher
May 23, 2025

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies - Zacks Investment Research

May 23, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals CEO Set to Reveal Latest Corporate Strategy at Major Jefferies Healthcare Conference - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $50.88 Average Target Price from Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

Mizuho Securities Adjusts Corbus Pharmaceuticals Price Target to $32 From $42, Maintains Outperform Rating - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Mizuho Cuts Price Target on Corbus Pharmaceuticals Holdings to $32 From $42, Keeps Outperform Rating - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Cannabis Stock Movers For May 20, 2025 - Benzinga

May 20, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals appoints new board chair - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals appoints new board chair By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Appoints New Chair of the Board - TipRanks

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals (CRBP) Names New Chair to Board of Direct - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

Corbus Pharmaceuticals Appoints Industry Leader as Chair with 3 Major Clinical Readouts Coming - Stock Titan

May 19, 2025
pulisher
May 16, 2025

(CRBP) Investment Analysis - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Is Small-Cap Corbus Pharma a Worthy Cannabis Investment? - sharewise

May 16, 2025
pulisher
May 13, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Barclays PLC - Defense World

May 13, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Has $76,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 13, 2025
pulisher
May 12, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Tower Research Capital LLC TRC - Defense World

May 12, 2025
pulisher
May 10, 2025

Oppenheimer Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $56.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

B. Riley Expects Reduced Earnings for Corbus Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $40.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

Wedbush Expects Weaker Earnings for Corbus Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Issues Negative Forecast for CRBP Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

May 09, 2025
pulisher
May 09, 2025

Royal Bank of Canada Has Lowered Expectations for Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price - Defense World

May 09, 2025
pulisher
May 08, 2025

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold? - Zacks Investment Research

May 08, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 07, 2025
pulisher
May 07, 2025

CRBP: RBC Capital Lowers Price Target, Maintains Outperform Rati - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Oppenheimer Lowers Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Target Price Reduced by Analyst | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Target Price Adjusted by RBC Capital | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

CRBP: HC Wainwright & Co. Lowers Price Target for Corbus Pharmaceuticals | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Oppenheimer Adjusts Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

RBC Cuts Price Target on Corbus Pharmaceuticals Holdings to $58 From $65, Keeps Outperform, Speculative Risk - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Sees Price Target Reduction | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals: Q1 Earnings Snapshot - CTPost

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire

May 07, 2025

Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Altmeyer Anne
Director
May 30 '25
Sale
7.25
1,392
10,096
1,391
Smethurst Dominic
Chief Medical Officer
Mar 06 '25
Sale
6.78
6,393
43,330
70,807
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):